Treatment of Xerostomia by Herbal Preparation

May 12, 2013 updated by: Jin-sung Kim, Korea Health Industry Development Institute

Efficacy of Yukmijihwang-tang on Xerostomia in the Elderly: A Randomized,Double-blind, Placebo-controlled, Two-center Trial

The aims of this study are to investigate the effect of famous herbal formula extract on xerostomia, and to determine whether this formula affect various xerostomia-related questionnaires, salivary flow rate, residual saliva and salivary tests.

Study Overview

Detailed Description

Xerostomia is a condition related to both decrease in the amount of saliva produced and a change in its composition, therefore causing dry mouth.It can cause severe decline in quality of life and up to date, there have been few effective treatments for xerostomia.

The purpose of the current trial is to investigate the effect of herbal extract granule named Yukmijihwang-tang (YMT) on dry mouth. The trial is a randomized, double-blinded, placebo-controlled, 2-arm, 2-centered study. Ninety-six patients with xerostomia will be randomly assigned to one of the 2 groups consisting of YMT or placebo. The assigned treatments will last for 8 weeks and the follow-up period will be 2 weeks.

The primary outcomes are Visual analogue scale (VAS) for xerostomia.

The present study is designed to examine the safety and efficacy of YMT on xerostomia. Our study provides the clinical evidence of a new therapeutic strategy for xerostomia.

Study Type

Interventional

Enrollment (Anticipated)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 130-872
        • Recruiting
        • Kyung Hee University Oriental Medicine Hospital
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Jae-Woo Park, doctorate

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age of 60 - 80
  2. The visual analog scale for xerostomia must represent more than 4 points during 2wks prior to enrollment
  3. One who has less than 0.3 ml/min of unstimulated salivary flow rate
  4. One who has complained of xerostomia for at least 3months
  5. One who is able to read, write, hear, see something
  6. One who agree on not taking other therapies during experimental period
  7. One who agree on consent form

Exclusion Criteria:

  1. One who is taking the treatment for autoimmune disease such as sjogren's disease, rheumatic disease, systemic lupus erythematosus etc
  2. One who has the history of taking radiotherapy on head and neck or history of organ transplantation
  3. One who has severe mental illness such as depression
  4. One who takes oriental medicine or health functional food within 2 wks before enrollment
  5. One who takes the remedies on the purpose of relieving xerostomia such as pilocarpine, cevimeline, gargle solution, frequent gum use, intra oral devices and toothpaste etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Yukmijihwang-tang
Yukmijihwang-tang: Real herbal extract granule
The herbal extract granule, Yukmijihwang-tang granule, consists of 6 herbs. Ingredients: Rehmanniae Radix, Deoscoreae Radix, Corni Fructus, Hoelen, Alismatis Radix, Paeoniae Radicis Cortex. Dosage and frequency: 1 pack (3g), 3 packs per day (2 hours after morning, afternoon and evening meal)
Other Names:
  • Hexalong Granule
Placebo Comparator: Yukmijihwang-tang_Placebo
Yukmijihwang-tang_Placebo: Placebo herbal extract granule
The Yukmijihwang-tang_Placebo has the same form, color and flavor as experimental intervention (Yukmijihwang-tang). The dosage, frequency and duration is also the same as experimental intervention (Yukmijihwang-tang).
Other Names:
  • Hexalong Granule Placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS) for xerostomia
Time Frame: Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)
A 100 mm measurement instrument will be given to the patient and he will be instructed to indicate his severity of xerostomia in relation to the 2 extremes (0: no fatigue, 100: very severe fatigue).
Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Unstimulated Salivary Flow Rate (USFR) and Stimulated salivary flow rate (SSFR)
Time Frame: Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)
Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)
Residual saliva
Time Frame: Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)
Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)
Salivary IgA, Chromogranin A, Cortisol
Time Frame: Visit 1(0week), Visit 3(8week)
Visit 1(0week), Visit 3(8week)
Dry Mouth Symptom Questionnaire(DMSQ)
Time Frame: Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)
DMSQ is composed of 10 questions associated with the severity of xerostomia and various behaviors related to xerostomia
Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jinsung Kim, doctorate, Kyung Hee University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Anticipated)

September 1, 2013

Study Completion (Anticipated)

November 1, 2013

Study Registration Dates

First Submitted

April 13, 2012

First Submitted That Met QC Criteria

April 16, 2012

First Posted (Estimate)

April 18, 2012

Study Record Updates

Last Update Posted (Estimate)

May 14, 2013

Last Update Submitted That Met QC Criteria

May 12, 2013

Last Verified

May 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Xerostomia

Clinical Trials on Herbal extract granule

Subscribe